Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P 500 Capped 35/20 Health Care (EUR Hedged) |
| Investment focus | Equity, United States, Health Care |
| Fund size | EUR 119 m |
| Total expense ratio | 0.18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency hedged |
| Volatility 1 year (in EUR) | 17.99% |
| Inception/ Listing Date | 15 June 2020 |
| Distribution policy | Distributing |
| Distribution frequency | Quarterly |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 30 November |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | Unknown |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| Eli Lilly & Co. | 14.93% |
| Johnson & Johnson | 8.70% |
| AbbVie, Inc. | 7.03% |
| UnitedHealth Group | 5.21% |
| Merck & Co., Inc. | 4.57% |
| Abbott Laboratories | 3.92% |
| Thermo Fisher Scientific | 3.90% |
| Intuitive Surgical | 3.59% |
| Amgen, Inc. | 3.25% |
| Gilead Sciences, Inc. | 2.73% |
| United States | 95.35% |
| Ireland | 2.81% |
| Other | 1.84% |
| Health Care | 98.16% |
| Other | 1.84% |
| YTD | +1.55% |
| 1 month | +5.15% |
| 3 months | +9.12% |
| 6 months | +15.26% |
| 1 year | +10.57% |
| 3 years | +14.10% |
| 5 years | +28.04% |
| Since inception (MAX) | +50.07% |
| 2025 | +11.76% |
| 2024 | -0.15% |
| 2023 | -0.83% |
| 2022 | -5.83% |
| Current dividend yield | 1.23% |
| Dividends (last 12 months) | EUR 0.09 |
| Period | Dividend in EUR | Dividend yield in % |
|---|---|---|
| 1 Year | EUR 0.09 | 1.36% |
| 2025 | EUR 0.09 | 1.38% |
| 2024 | EUR 0.09 | 1.32% |
| 2023 | EUR 0.08 | 1.24% |
| 2022 | EUR 0.08 | 1.12% |
| Volatility 1 year | 17.99% |
| Volatility 3 years | 14.71% |
| Volatility 5 years | 16.00% |
| Return per risk 1 year | 0.59 |
| Return per risk 3 years | 0.31 |
| Return per risk 5 years | 0.32 |
| Maximum drawdown 1 year | -14.94% |
| Maximum drawdown 3 years | -18.79% |
| Maximum drawdown 5 years | -18.79% |
| Maximum drawdown since inception | -18.79% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | IUHE | - - | - - | - |
| Euronext Amsterdam | EUR | IUHE | IUHE NA | IUHE.AS |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 45 | 0.35% p.a. | Distributing | Sampling |